Funding 2 Programme Date definition

Funding 2 Programme Date means 19 January, 2005;
Funding 2 Programme Date means [o], 2005
Funding 2 Programme Date means 19 January 2005.

Examples of Funding 2 Programme Date in a sentence

  • The Cash Manager undertakes (to the extent to which the same is within its control) that at the Funding 2 Programme Date the Funding 2 GIC Account will be operative and that the Cash Manager will not knowingly create or permit to subsist any Security Interest in relation to the Funding 2 GIC Account other than as created under or permitted pursuant to the Funding 2 Deed of Charge.

  • The Cash Manager undertakes (to the extent to which the same is within its control) that at the Funding 2 Programme Date the Funding 2 Transaction Account will be operative and that the Cash Manager will not knowingly create or permit to subsist any Security Interest in relation to the Funding 2 Transaction Account other than as created under or permitted pursuant to the Funding 2 Deed of Charge.

  • References herein to the "Funding 2 Share" shall, from (and including) the Funding 2 Programme Date to (but excluding) the first Closing Date in relation to the issue of Notes by a Funding 2 Issuer, mean the Initial Funding 2 Share and thereafter shall mean the Current Funding 2 Share.

  • The Issuer Cash Manager undertakes (to the extent to which the same is within its control in its capacity as Issuer Cash Manager) that at the Funding 2 Programme Date the Issuer Bank Accounts will be operative and that the Issuer Cash Manager will not knowingly create or permit to subsist any Security Interest in relation to the Issuer Bank Accounts other than as created under or permitted pursuant to the Issuer Deed of Charge.

  • On the first Closing Date following the Funding 2 Programme Date, and on subsequent Closing Dates, the Master Issuer may issue Issuer Notes constituted by the Issuer Trust Deed.

  • The Issuer Cash Manager hereby confirms that the Issuer Bank Accounts have been established on or before the date hereof and that the mandates in the agreed form will apply thereto at the Funding 2 Programme Date.

  • The Cash Manager undertakes (to the extent to which the same is within its control) that at the Funding 2 Programme Date the Funding 2 Transaction Account will be operative and that the Cash Manager will not knowingly create or permit to subsist any Funding 1 Security Trustee in relation to the Funding 2 Transaction Account other than as created under or permitted pursuant to the Funding 2 Deed of Charge.

  • The Cash Manager undertakes (to the extent to which the same is within its control) that at the Funding 2 Programme Date the Funding 2 GIC Account will be operative and that the Cash Manager will not knowingly create or permit to subsist any Funding 2 Security Trustee in relation to the Funding 2 GIC Account other than as created under or permitted pursuant to the Funding 2 Deed of Charge.

  • The Mortgage Trustee holds the assigned mortgage loans as bare trustee for Funding 1, the Seller and following the Funding 2 Programme Date, Funding 2, pursuant to the terms of the Mortgages Trust Deed.


More Definitions of Funding 2 Programme Date

Funding 2 Programme Date. On the Funding 2 Programme Date, the Seller shall deliver to each Funding Security Trustee, each Funding Beneficiary and the Mortgages Trustee or the representative of such party (or procure such delivery to such party) an original power of attorney in the form set out in Part 2 of Schedule 10 (Power of Attorney in favour of the Mortgages Trustee, Funding, Funding 2, the Security Trustee and the Funding 2 Security Trustee) duly executed by the Seller. On the delivery of such power of attorney in accordance with the previous sentence, the parties hereto agree that the power of attorney delivered by the Seller on 26 March 2001 in accordance with Clause 3.1(a) shall terminate and be of no further effect.

Related to Funding 2 Programme Date

  • Programme Date means the date of this Base Prospectus.

  • Funding Period means the period beginning on the Closing Date and ending on the first to occur of (a) the Distribution Date on which the amount on deposit in the Pre-Funding Account (after giving effect to any transfers therefrom in connection with the transfer of Subsequent Contracts to the Trust on such Distribution Date) is less than $150,000, (b) the date on which an Event of Termination occurs, (c) the date on which an Insolvency Event occurs with respect to the Trust Depositor and (d) the close of business on the date which is 90 days from and including the Closing Date.

  • Child day program means a regularly operating service arrangement for children where, during the absence of a parent or guardian, a person or organization has agreed to assume responsibility for the supervision, protection, and well-being of a child under the age of 13 for less than a 24-hour period.

  • Scheduled Commercial Operation Date shall have the meaning ascribed to it in Clause 5.4.1;

  • Programme Effective Date means 5 December 2017.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Amortization Commencement Date means the date on which an Amortization Event is deemed to occur pursuant to Section 20 hereof.

  • Activation Date means the date upon which MLBFS shall cause the WCMA Line of Credit to be fully activated under MLPF&S' computer system as part of the WCMA Program.

  • Rebalance Business Day means any day which is a, Exchange Business Day and also a day on which commercial banks and foreign exchange markets settle payment in the country in which the relevant Reference Asset is admitted to trading or any other day designated as a Rebalance Business Day by the Issuer.

  • Distribution Commencement Date means the Issue Date or such other date as may be specified as the Distribution Commencement Date on the face of such Perpetual Security;

  • Funding Cycle means the period of time commencing with the Notice of Funding Availability or Notice of Credit Availability pursuant to this rule chapter and concluding with the issuance of allocations or loans to Applicants who applied during a given Application Period.

  • Milestone Date means the target date set out against the relevant Milestone in the Implementation Plan by which the Milestone must be Achieved;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Scheduled Completion Date shall be the date set forth in Clause 10.3;

  • Draw Date means, with respect to any Insured Distribution Date, the third Business Day immediately preceding such Insured Distribution Date.

  • Phase II Clinical Trial means a study in humans of the safety, dose ranging and efficacy of a product, which is prospectively designed to generate sufficient data (if successful) to commence a Phase III Clinical Trial or to file for accelerated approval, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(b) or its foreign equivalents.

  • Term SOFR Replacement Date has the meaning specified in Section 3.03(b).

  • Initial Maturity Date means the earlier of (i) December 1, 2015 (the "Scheduled Initial Maturity Date"), and (ii) the date on which the unpaid principal balance of this Note becomes due and payable by acceleration or otherwise pursuant to the Loan Documents or the exercise by Lender of any right or remedy thereunder.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Development Period means the period from the date of this Agreement until the Appointed Date;

  • Additional SDU Study means a deliverability study that a Developer may elect to pursue as that term is defined in OATT Section 25 (OATT Attachment S). For purposes of Section 23.4.5 of this Attachment H, “Affiliated Entity” shall mean, with respect to a person or Entity:

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • (3) PROGRAM.—The term program’ means

  • Accumulation Commencement Date means January 1, 2021, or such later date as the Calculation Agent on behalf of the Issuer determines in accordance with Section 2.11 hereof.

  • Funding Date is any date on which a Credit Extension is made to or for the account of Borrower which shall be a Business Day.